SCHEMBL30774783

SCHEMBL30774783

N#Cc1ccc(-c2cncc3c2OCCN3S(=O)(=O)C2CN(c3cccc(F)c3)C2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 3/20 0.38
▸ SLC22A12 Q96S37 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ AKT1 P31749 3/20 0.33
▸ PIK3CA P42336 3/20 0.33
▸ MTOR P42345 3/20 0.33
▸ CYP11B1 P15538 3/20 0.33
▸ CYP11B2 P19099 3/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ NTRK3 Q16288 1/20 0.33
▸ NTRK2 Q16620 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ NR3C2 P08235 1/20 0.32
▸ CTSS P25774 1/20 0.32
▸ GRIA2 P42262 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774639 0.90 SLC22A12 (0.40) SLC22A12AKT1PIK3CAMTORHSD11B1
SCHEMBL30773947 0.89 HTR6 (0.43) HTR6CYP11B1CYP11B2RORC
SCHEMBL30774485 0.86 ROCK2 (0.37) HTR6CYP3A4CYP11B1CYP11B2HTR1A
SCHEMBL30774558 0.84 HTR6 (0.52) HTR6SLC22A12CYP11B1CYP11B2RORC
SCHEMBL31635537 0.83 USP30 (0.43) SLC22A12AKT1CYP11B1CYP11B2PIK3CD
SCHEMBL30773994 0.83 SLC22A12 (0.41) SLC22A12CYP11B1CYP11B2HSD11B1KCNH2
SCHEMBL30774858 0.82 CYP11B1 (0.41) CYP11B1CYP11B2HSD11B1RORC
SCHEMBL30774471 0.82 PKM (0.41) SLC22A12CYP11B1CYP11B2
SCHEMBL30774765 0.81 CYP11B1 (0.40) SLC22A12PIK3CACYP11B1CYP11B2DRD2
SCHEMBL30774403 0.80 ROCK2 (0.44) AKT1PIK3CAMTORCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US claimed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP claimed
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 HTR6 3964/4885SLC22A12 3869/4885CYP3A4 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback